Grantham, Mayo, Van Otterloo & Co (GMO)’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-49,600
| Closed | -$878K | – | 791 |
|
|
2022
Q3 | $878K | Sell |
49,600
-62,400
| -56% | -$1.1M | 0.01% | 511 |
|
|
2022
Q2 | $1.95M | Buy |
112,000
+19,100
| +21% | +$333K | 0.01% | 440 |
|
|
2022
Q1 | $1.94M | Buy |
92,900
+47,700
| +106% | +$998K | 0.01% | 451 |
|
|
2021
Q4 | $804K | Buy |
+45,200
| New | +$804K | ﹤0.01% | 560 |
|
|
2021
Q1 | – | Sell |
-66,100
| Closed | -$1.21M | – | 963 |
|
|
2020
Q4 | $1.21M | Sell |
66,100
-99,400
| -60% | -$1.81M | 0.01% | 537 |
|
|
2020
Q3 | $2.11M | Buy |
165,500
+50,200
| +44% | +$639K | 0.02% | 397 |
|
|
2020
Q2 | $1.27M | Buy |
115,300
+89,400
| +345% | +$982K | 0.01% | 493 |
|
|
2020
Q1 | $270K | Buy |
+25,900
| New | +$270K | ﹤0.01% | 668 |
|
|
2019
Q1 | – | Sell |
-16,100
| Closed | -$244K | – | 749 |
|
|
2018
Q4 | $244K | Sell |
16,100
-3,800
| -19% | -$57.6K | ﹤0.01% | 491 |
|
|
2018
Q3 | $400K | Hold |
19,900
| – | – | ﹤0.01% | 452 |
|
|
2018
Q2 | $388K | Hold |
19,900
| – | – | ﹤0.01% | 474 |
|
|
2018
Q1 | $272K | Hold |
19,900
| – | – | ﹤0.01% | 513 |
|
|
2017
Q4 | $270K | Sell |
19,900
-3,200
| -14% | -$43.4K | ﹤0.01% | 517 |
|
|
2017
Q3 | $363K | Buy |
23,100
+1,900
| +9% | +$29.9K | ﹤0.01% | 425 |
|
|
2017
Q2 | $365K | Buy |
21,200
+2,400
| +13% | +$41.3K | ﹤0.01% | 417 |
|
|
2017
Q1 | $287K | Buy |
+18,800
| New | +$287K | ﹤0.01% | 415 |
|
|
2016
Q3 | – | Sell |
-29,200
| Closed | -$348K | – | 582 |
|
|
2016
Q2 | $348K | Buy |
+29,200
| New | +$348K | ﹤0.01% | 500 |
|